You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

https://doi.org/10.1136/ebmed-2015-110307

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors GWR wrote the manuscript. AA contributed to the analysis, reviewed and approved the manuscript.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.